Chronic Inflammatory Demyelinating Polyneuropathy
Symptoms, Doctors, Treatments, Advances & More

Chronic Inflammatory Demyelinating Polyneuropathy Overview

Save information for later
Sign Up

Learn About Chronic Inflammatory Demyelinating Polyneuropathy

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Chronic Inflammatory Demyelinating Polyneuropathy Local Doctors?
Elite in Chronic Inflammatory Demyelinating Polyneuropathy
Neurology | Neuromusculoskeletal Medicine | Neurosurgery
Elite in Chronic Inflammatory Demyelinating Polyneuropathy
Neurology | Neuromusculoskeletal Medicine | Neurosurgery

Vickie & Jack Farber Institute For Neuroscience - Honickman Center

1101 Chestnut Street, Floor 10, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Marinos Dalakas is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Dalakas is rated as an Elite provider by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Hereditary Hyperekplexia, Chronic Polyradiculoneuritis, and Laminectomy. Dr. Dalakas is board certified in Neurology. Dr. Dalakas is currently accepting new patients.

Elite in Chronic Inflammatory Demyelinating Polyneuropathy
Elite in Chronic Inflammatory Demyelinating Polyneuropathy

Clinical Research Center

4350 Shawnee Mission Parkway, 
Fairway, KS 
Experience:
38+ years
Languages Spoken:
English, Arabic, French
Accepting New Patients
Offers Telehealth

Mazen Dimachkie is a Neurologist practicing medicine in Fairway, Kansas. He has been practicing medicine for over 38 years. Dr. Dimachkie is rated as an Elite provider by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Myositis, Inclusion Body Myositis, Myasthenia Gravis, Thymectomy, and Tissue Biopsy. Dr. Dimachkie is board certified in United Council For Neurologic Subspecialties, Clinical Neuromuscular Pathology - 2015 , American Board Of Psychiatry And Neurology, Neuromuscular Medicine - 2008 , American Board Of Psychiatry And Neurology, Clinical Neurophysiology - 1996 , and American Board Of Psychiatry And Neurology, Neurology - 1995. Dr. Dimachkie is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Chronic Inflammatory Demyelinating Polyneuropathy
Elite in Chronic Inflammatory Demyelinating Polyneuropathy

Clinical Research Center

4350 Shawnee Mission Parkway, 
Fairway, KS 
Experience:
30+ years
Languages Spoken:
English, Hindi, Telugu
Accepting New Patients
Offers Telehealth

Mamatha Pasnoor is a Neurologist practicing medicine in Fairway, Kansas. She has been practicing medicine for over 30 years. Dr. Pasnoor is rated as an Elite provider by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Peripheral Neuropathy, Thymectomy, and Tissue Biopsy. Dr. Pasnoor is board certified in American Board Of Psychiatry And Neurology, Clinical Neurophysiology - 2009 , American Board Of Psychiatry And Neurology, Neuromuscular Medicine - 2008 , and American Board Of Psychiatry And Neurology, Neurology - 2006. Dr. Pasnoor is currently accepting new patients.

What are the Latest Advances for Chronic Inflammatory Demyelinating Polyneuropathy?
What are the latest Chronic Inflammatory Demyelinating Polyneuropathy Clinical Trials?
A Phase 3, Randomized, Double-blind, Study Evaluating Efficacy and Safety of Riliprubart Versus Intravenous Immunoglobulin (IVIg) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy

Summary: The purpose of the study is to evaluate efficacy of riliprubart compared to IVIg in adult participants with CIDP who are receiving maintenance treatment with IVIg. The study duration will be for a maximum of 109 weeks including screening, treatment phases, and follow-up.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Double-blind, Randomized, Multi-Center Study Investigating Efficacy and Safety of Two Different Dosages of Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Summary: The current study is being conducted to assess the efficacy and safety of KIg10 (Intravenous Human Immune globulin 10%) at two different dosages as maintenance therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) following 21 weeks of treatment.